Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 3:57 pm Purchase |
2024-09-30 | 13G | KalVista Pharmaceuticals, Inc. KALV |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,328,904 9.990% |
1,644,899 (+61.29%) |
Filing History |
| 2024-11-14 3:52 pm Sale |
2024-09-30 | 13G | Cogent Biosciences, Inc. COGT |
SUVRETTA CAPITAL MANAGEMENT, LLC | 0 0.000% |
-5,481,034 (Position Closed) |
Filing History |
| 2024-11-14 3:41 pm Sale |
2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN |
SUVRETTA CAPITAL MANAGEMENT, LLC | 0 0.000% |
-5,837,126 (Position Closed) |
Filing History |
| 2024-10-22 3:32 pm Purchase |
2024-08-28 | 13G | ProKidney Corp. PROK |
SUVRETTA CAPITAL MANAGEMENT, LLC | 13,198,766 10.470% |
8,473,418 (+179.32%) |
Filing History |
| 2024-10-17 9:21 pm Purchase |
2024-02-06 | 13G | 89bio, Inc. ETNB |
SUVRETTA CAPITAL MANAGEMENT, LLC | 7,991,644 7.500% |
3,103,210 (+63.48%) |
Filing History |
| 2024-09-30 5:18 pm Purchase |
2024-09-26 | 13D | Benitec Biopharma Inc. BNTC |
SUVRETTA CAPITAL MANAGEMENT, LLC | 8,829,053 49.900% |
7,128,203 (+419.10%) |
Filing History |
| 2024-08-12 4:52 pm Purchase |
2024-07-31 | 13G | PepGen Inc. PEPG |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,660,932 5.100% |
1,660,932 (New Position) |
Filing History |
| 2024-05-28 4:34 pm Purchase |
2024-05-17 | 13G | Erasca, Inc. ERAS |
SUVRETTA CAPITAL MANAGEMENT, LLC | 13,768,039 5.500% |
13,768,039 (New Position) |
Filing History |
| 2024-05-13 5:03 pm Purchase |
2024-05-03 | 13G | Abeona Therapeutics Inc. ABEO |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,685,503 9.300% |
3,685,503 (New Position) |
Filing History |
| 2024-04-29 4:08 pm Purchase |
2024-04-22 | 13D | Benitec Biopharma Inc. BNTC |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,700,850 19.990% |
1,438,007 (+547.10%) |
Filing History |
| 2024-04-15 4:38 pm Purchase |
2024-04-05 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,720,000 9.300% |
1,720,000 (New Position) |
Filing History |
| 2024-02-13 5:28 pm Purchase |
2023-12-31 | 13G | Spyre Therapeutics, Inc. SYRE |
SUVRETTA CAPITAL MANAGEMENT, LLC | 412,395 1.000% |
412,395 (New Position) |
Filing History |
| 2024-02-13 5:27 pm Sale |
2023-12-31 | 13G | ProKidney Corp. PROK |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,725,348 7.000% |
-1,554,827 (-24.76%) |
Filing History |
| 2024-02-13 5:26 pm Purchase |
2023-12-31 | 13G | Mereo BioPharma Group plc MREO |
SUVRETTA CAPITAL MANAGEMENT, LLC | 36,854,190 5.300% |
32,000 (+0.09%) |
Filing History |
| 2024-02-13 5:23 pm Purchase |
2023-12-31 | 13G | Kura Oncology, Inc. KURA |
SUVRETTA CAPITAL MANAGEMENT, LLC | 7,472,343 9.990% |
1,095,528 (+17.18%) |
Filing History |
| 2024-02-13 5:19 pm Purchase |
2023-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,684,005 7.800% |
887,626 (+49.41%) |
Filing History |
| 2024-02-13 5:16 pm Purchase |
2023-12-31 | 13G | Benitec Biopharma Inc. BNTC |
SUVRETTA CAPITAL MANAGEMENT, LLC | 262,843 9.990% |
262,843 (New Position) |
Filing History |
| 2024-02-13 5:08 pm Purchase |
2023-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,572,836 5.700% |
723,898 (+18.81%) |
Filing History |
| 2024-02-13 12:29 pm Sale |
2023-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
SUVRETTA CAPITAL MANAGEMENT, LLC | 9,534,837 9.990% |
-57,375 (-0.60%) |
Filing History |
| 2024-02-13 12:24 pm Purchase |
2023-12-31 | 13G | 89bio, Inc. ETNB |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,888,434 5.200% |
80,060 (+1.67%) |
Filing History |